Adverse drug reactions and risk factor association of antitubercular drugs during intensive phase of DOTS in patients of Northern India

Identification of patient at higher risk with timely intervention can reduce morbidity and mortality. ADRs are a common occurrence with anti-tubercular drugs as DOTS regimen.